Maribor University Medical Centre is one of the largest medical institutions in Slovenia. It is located in Maribor, in the Magdalena District, on the right bank of Drava river.

There are 1,266 beds in University Medical Centre Maribor.

During the past decade, University Medical Centre Maribor conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 6 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 4 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Medical Centre Maribor" #1 sponsor was "University Medical Centre Maribor" with 9 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Abivax S.A." with 2 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Medical Centre Maribor" #1 collaborator was "University Medical Centre Maribor" with 3 trials as a collaborator, "Health Research Board, Ireland" with 2 trials as a collaborator, "ANZICS Clinical Trials Group" with 1 trials as a collaborator, "ASL Parma" with 1 trials as a collaborator and "Aristotle University Of Thessaloniki" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "University Medical Centre Maribor" are "Alzheimer's Disease" (2 trials), "Aneurysmal Subarachnoid Hemorrhage" (2 trials), "Breast Cancer" (2 trials), "Multiple Sclerosis" (2 trials) and "Multiple Sclerosis, Relapsing-Remitting" (2 trials). Many other conditions were trialed in "University Medical Centre Maribor" in a lesser frequency.

Most popular intervention types in "University Medical Centre Maribor" are "Drug" (25 trials), "Other" (5 trials), "Biological" (4 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Carboplatin" (2 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials) and "JNJ-78934804" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Medical Centre Maribor" are 33 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "University Medical Centre Maribor". undefined are not yet recruiting, 12 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in University Medical Centre Maribor, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University Medical Centre Maribor, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".

University Medical Centre Maribor has several departments that took part in Clinical trials: "Univerzitetni klinični center Maribor; Oddelek za onkologijo" - 3 trials, "UKC Maribor Dermatology clinic" - 2 trials